Claritev says DOJ antitrust probe has not named company as target

Claritev

Claritev

CTEV

0.00
  • Claritev issued a Regulation FD clarification addressing a May 14, 2026 article that alleged the DOJ had launched a criminal antitrust probe into the company.
  • The company disclosed it received a confidential DOJ Antitrust Division grand jury subpoena in August 2024 tied to an investigation involving health insurance.
  • Claritev said it has cooperated with the DOJ and has not been told at any point over the past two years that it is a target of the investigation.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Claritev Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001793229-26-000052), on May 18, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.